COVID19 pandemic has badly affected thoracic surgical services. In this difficult time Thoracic surgeons all over the world are boldly managing thoracic malignancies and life-threatening problems of benign thoracic diseases. Infection control, safety of patients & healthcare personnel remains the cornerstone. In this article we present our experience of Thoracic surgery during this pandemic. Our results & experience are similar to the guidelines & survey reports published by thoracic surgeons till date.
{"title":"Our experience of thoracic surgery during COVID19 pandemic","authors":"A. Chakrabarti, Manujesh Bandyopadhyay","doi":"10.4103/jacp.jacp_38_20","DOIUrl":"https://doi.org/10.4103/jacp.jacp_38_20","url":null,"abstract":"COVID19 pandemic has badly affected thoracic surgical services. In this difficult time Thoracic surgeons all over the world are boldly managing thoracic malignancies and life-threatening problems of benign thoracic diseases. Infection control, safety of patients & healthcare personnel remains the cornerstone. In this article we present our experience of Thoracic surgery during this pandemic. Our results & experience are similar to the guidelines & survey reports published by thoracic surgeons till date.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"64 - 68"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43980112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: It is estimated that 5,500 adolescents started using tobacco every day in India. The prevention of tobacco use in young Indians appears to be one of the largest opportunities for controlling this ever-growing epidemic. In India, like in other developing countries, the most susceptible time for initiation of tobacco is during youth, that is in the age group of 15–24 years. Material and Methods: This cross-sectional study was conducted in Kalyanpuri, a resettlement colony in New Delhi, India. The study included males aged 15–24 years residing in the study area at the time of survey. A semi-structured interview schedule was designed and translated into Hindi to elicit information on tobacco use. Results: Prevalence of tobacco use (ever user) was found to be 31.3%. Among ever users, 225 (27.7%) were current users and 9 (3.6%) were past users. Peer pressure (140, 62.2%) was found to be most common reason for initiation, whereas habit (143, 63.5%) of having tobacco was most common reason for continuation of tobacco use.
{"title":"A cross-sectional study on tobacco use prevalence and reasons for its use among male youth in a resettlement colony of Delhi","authors":"V. Yadav, D. Dabar","doi":"10.4103/jacp.jacp_32_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_32_19","url":null,"abstract":"Introduction: It is estimated that 5,500 adolescents started using tobacco every day in India. The prevention of tobacco use in young Indians appears to be one of the largest opportunities for controlling this ever-growing epidemic. In India, like in other developing countries, the most susceptible time for initiation of tobacco is during youth, that is in the age group of 15–24 years. Material and Methods: This cross-sectional study was conducted in Kalyanpuri, a resettlement colony in New Delhi, India. The study included males aged 15–24 years residing in the study area at the time of survey. A semi-structured interview schedule was designed and translated into Hindi to elicit information on tobacco use. Results: Prevalence of tobacco use (ever user) was found to be 31.3%. Among ever users, 225 (27.7%) were current users and 9 (3.6%) were past users. Peer pressure (140, 62.2%) was found to be most common reason for initiation, whereas habit (143, 63.5%) of having tobacco was most common reason for continuation of tobacco use.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"76 - 80"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47461625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aspergillus species cause a wide spectrum of pulmonary disease including allergic, saprophytic, semi-invasive and invasive aspergillosis. Host immune system is the major determinant of the pattern of illness in human beings. Several chronic forms of Aspergillus infections have been described which include chronic cavitary pulmonary aspergillosis (CCPA), chronic fibrotic pulmonary aspergillosis (CFPA) and chronic necrotizing pulmonary aspergillosis (CNPA). Chronic cavitary pulmonary aspergillosis usually runs a progressive course, affects apparently immunocompetent individuals with a pre-existing lung disease. Diagnosis depends on presence of constitutional and pulmonary symptoms, suggestive radiological changes and microbiological or serological evidence of Aspergillus infection. We hereby present a case of 28 years immunocompetent male who had prior history of pulmonary tuberculosis and was subsequently diagnosed as chronic cavitary pulmonary aspergillosis.
{"title":"A case of chronic cavitory pulmonary aspergillosis, a rare entity","authors":"S. Das, Soumyadeep Ghosh, Gopal Sasmal","doi":"10.4103/jacp.jacp_2_20","DOIUrl":"https://doi.org/10.4103/jacp.jacp_2_20","url":null,"abstract":"Aspergillus species cause a wide spectrum of pulmonary disease including allergic, saprophytic, semi-invasive and invasive aspergillosis. Host immune system is the major determinant of the pattern of illness in human beings. Several chronic forms of Aspergillus infections have been described which include chronic cavitary pulmonary aspergillosis (CCPA), chronic fibrotic pulmonary aspergillosis (CFPA) and chronic necrotizing pulmonary aspergillosis (CNPA). Chronic cavitary pulmonary aspergillosis usually runs a progressive course, affects apparently immunocompetent individuals with a pre-existing lung disease. Diagnosis depends on presence of constitutional and pulmonary symptoms, suggestive radiological changes and microbiological or serological evidence of Aspergillus infection. We hereby present a case of 28 years immunocompetent male who had prior history of pulmonary tuberculosis and was subsequently diagnosed as chronic cavitary pulmonary aspergillosis.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"106 - 109"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42119127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
H. Kumar, A. Verma, A. Pandey, Utkarsh Srivastava, M. Pandey, Rishabh Chaudhary, S. Kant
Context: Chronic obstructive pulmonary disease (COPD) is the second leading cause of mortality in India, cardiovascular disease (CVD) comorbidity further increases morbidity and mortality of COPD. Early detection of CVD by echocardiography in COPD helps to reduce mortality and morbidity. Objective: We aimed to assess the echocardiographic findings in stable COPD patients. Materials and Methods: Patients with stable COPD, confirmed by spirometry, were recruited from the two tertiary care centre of India between August 2017 and August 2019. After thorough clinical examinations, patients have undergone echocardiography for CVD evaluation. Results: A total of 110 COPD patients were recruited, 91 male and 19 female. On echocardiographic evaluation, pulmonary arterial hypertension (PAH) was seen in 45.5% of COPD with mild, moderate, severe 14.5%, 11% and 20% respectively. Cor-pulmonale was seen in 9.1%. Left ventricular hypertrophy (LVH), left ventricular diastolic dysfunction (LVDD) and left ventricular systolic dysfunction (LVSD) was seen in 11%, 39.1% and 13.6% of COPD respectively. CVD involvement was more common in very severe COPD (40.1%). Conclusion: In this study, 78.2% of COPD have at least one form of CVD as co-morbidity. A simple, cheaper, non-invasive, widely an available investigation like echocardiography is useful to detect CVD at an early stage.
{"title":"Echocardiographic evaluation of stable chronic obstructive pulmonary disease (COPD) patients","authors":"H. Kumar, A. Verma, A. Pandey, Utkarsh Srivastava, M. Pandey, Rishabh Chaudhary, S. Kant","doi":"10.4103/jacp.jacp_40_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_40_19","url":null,"abstract":"Context: Chronic obstructive pulmonary disease (COPD) is the second leading cause of mortality in India, cardiovascular disease (CVD) comorbidity further increases morbidity and mortality of COPD. Early detection of CVD by echocardiography in COPD helps to reduce mortality and morbidity. Objective: We aimed to assess the echocardiographic findings in stable COPD patients. Materials and Methods: Patients with stable COPD, confirmed by spirometry, were recruited from the two tertiary care centre of India between August 2017 and August 2019. After thorough clinical examinations, patients have undergone echocardiography for CVD evaluation. Results: A total of 110 COPD patients were recruited, 91 male and 19 female. On echocardiographic evaluation, pulmonary arterial hypertension (PAH) was seen in 45.5% of COPD with mild, moderate, severe 14.5%, 11% and 20% respectively. Cor-pulmonale was seen in 9.1%. Left ventricular hypertrophy (LVH), left ventricular diastolic dysfunction (LVDD) and left ventricular systolic dysfunction (LVSD) was seen in 11%, 39.1% and 13.6% of COPD respectively. CVD involvement was more common in very severe COPD (40.1%). Conclusion: In this study, 78.2% of COPD have at least one form of CVD as co-morbidity. A simple, cheaper, non-invasive, widely an available investigation like echocardiography is useful to detect CVD at an early stage.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"88 - 91"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44601492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
P. Bhattacharyya, S. Sengupta, D. Saha, Mintu Paul, Priyanka Choudhury, S. Dasgupta
Background: The prevalence of pulmonary hypertension (PH) in India remains unknown. The literature is scanty from the country regarding different types of PH. The etiological distribution of Group III PH in a pulmonologist’s practice, therefore, will be worthwhile to note. Method: We included patients with pulmonary hypertension following convenience sampling from those been diagnosed with PH in our pulmonary OPD services on the basis of a novel clinico-radio-echocardiographic criteria. They were then evaluated for the apparent and predominant underlying etiology. Patients with clear and defined diagnosis of COPD, asthma, DPLD, OSA and CTEPH were charted along with those having no obvious etiology but a history of treatment of tuberculosis in the past, along with a group marked as the “others” that consisted of a number of known (sarcoidosis, rheumatic heart disease, etc.) and some incompletely evaluated patients. Results: A total of 356 patients were recruited. The relative frequencies have been accounted to 35.81%, 20.66% and 13.77% for COPD, DPLD and asthma respectively. The patients with a history of TB without any other forthcoming etiology formed 12.67% of the group. The patients with OSA and CTEPH accounted for 2.75% of the group and the “Others” group occupied the rest 14.32%. Conclusion: Group III PH is found not infrequent in pulmonary practice and COPD tops the etiological list.
{"title":"Group III Pulmonary Hypertension: relative frequency of different etiologies in a referral pulmonary OPD","authors":"P. Bhattacharyya, S. Sengupta, D. Saha, Mintu Paul, Priyanka Choudhury, S. Dasgupta","doi":"10.4103/jacp.jacp_3_20","DOIUrl":"https://doi.org/10.4103/jacp.jacp_3_20","url":null,"abstract":"Background: The prevalence of pulmonary hypertension (PH) in India remains unknown. The literature is scanty from the country regarding different types of PH. The etiological distribution of Group III PH in a pulmonologist’s practice, therefore, will be worthwhile to note. Method: We included patients with pulmonary hypertension following convenience sampling from those been diagnosed with PH in our pulmonary OPD services on the basis of a novel clinico-radio-echocardiographic criteria. They were then evaluated for the apparent and predominant underlying etiology. Patients with clear and defined diagnosis of COPD, asthma, DPLD, OSA and CTEPH were charted along with those having no obvious etiology but a history of treatment of tuberculosis in the past, along with a group marked as the “others” that consisted of a number of known (sarcoidosis, rheumatic heart disease, etc.) and some incompletely evaluated patients. Results: A total of 356 patients were recruited. The relative frequencies have been accounted to 35.81%, 20.66% and 13.77% for COPD, DPLD and asthma respectively. The patients with a history of TB without any other forthcoming etiology formed 12.67% of the group. The patients with OSA and CTEPH accounted for 2.75% of the group and the “Others” group occupied the rest 14.32%. Conclusion: Group III PH is found not infrequent in pulmonary practice and COPD tops the etiological list.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"69 - 75"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47548212","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Corrosive esophageal injury caused by impacted button battery","authors":"Charulatha Ravindran, S. R, G. Jayaraman","doi":"10.4103/jacp.jacp_41_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_41_19","url":null,"abstract":"","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"110 - 111"},"PeriodicalIF":0.0,"publicationDate":"2020-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42640428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background and Objective: Several studies support high prevalence of obstructive sleep apnea (OSA) symptoms in patients with asthma. Our objective was to evaluate the relationship between OSA severity and level of asthma control if any and analyze sleep parameters in patients having different levels of asthma control. Methods: A cross-sectional study among asthma patients having symptoms of sleep-related breathing disorders. Eligible patients were assessed clinically and with sleep questionnaire including asthma control followed by level 1 Polysomnography. Results: Among 53 patients of asthma (mean age 48.16 years), OSA was present in 84.21% of uncontrolled asthma, 35% in partially controlled asthma, and 7.14% in well-controlled asthma. Uncontrolled asthma patients were associated with higher apnea/hypopnea index (AHI) (30.8±17.6 vs. 3.7±1.2; p-value < 0.0001), more time spent in non rapid eye movement (NREM) 1 stage (18.5±11.9% vs. 13.0±11.2% of total sleep time), higher nocturnal desaturation episodes (152.5±13 vs. 22.1±16.7; p-value < 0.001), and severe OSA in supine position (AHI 33.1±17.7 vs. 9.2±9.7; p-value < 0.001) compared with well-controlled asthma. Conclusion: There seems a strong relationship between desaturation events and higher AHI with poor level of asthma control, especially during supine position. OSA must be suspected in patients with uncontrolled asthma. An early detection and treatment of OSA may improve the level of asthma control as well as quality of life in such patients.
{"title":"Impact of obstructive sleep apnea and sleep parameters on level of asthma control","authors":"R. Dixit, Satyadeep Verma, M. Goyal","doi":"10.4103/jacp.jacp_8_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_8_19","url":null,"abstract":"Background and Objective: Several studies support high prevalence of obstructive sleep apnea (OSA) symptoms in patients with asthma. Our objective was to evaluate the relationship between OSA severity and level of asthma control if any and analyze sleep parameters in patients having different levels of asthma control. Methods: A cross-sectional study among asthma patients having symptoms of sleep-related breathing disorders. Eligible patients were assessed clinically and with sleep questionnaire including asthma control followed by level 1 Polysomnography. Results: Among 53 patients of asthma (mean age 48.16 years), OSA was present in 84.21% of uncontrolled asthma, 35% in partially controlled asthma, and 7.14% in well-controlled asthma. Uncontrolled asthma patients were associated with higher apnea/hypopnea index (AHI) (30.8±17.6 vs. 3.7±1.2; p-value < 0.0001), more time spent in non rapid eye movement (NREM) 1 stage (18.5±11.9% vs. 13.0±11.2% of total sleep time), higher nocturnal desaturation episodes (152.5±13 vs. 22.1±16.7; p-value < 0.001), and severe OSA in supine position (AHI 33.1±17.7 vs. 9.2±9.7; p-value < 0.001) compared with well-controlled asthma. Conclusion: There seems a strong relationship between desaturation events and higher AHI with poor level of asthma control, especially during supine position. OSA must be suspected in patients with uncontrolled asthma. An early detection and treatment of OSA may improve the level of asthma control as well as quality of life in such patients.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"1 - 5"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48832112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
K. Sharma, Avinash Jain, R. Takhar, Dps Sudan, V. Goyal, N. Goel, Vikram Singh
Background: Chronic obstructive pulmonary disease (COPD) is a spreading epidemic of a debilitating disease impairing the health-related quality of life (HRQoL) of the patients. This study was conducted to identify the relationship between BODE (body mass index, obstruction, dyspnea, exercise capacity) index and the St George’s Respiratory Questionnaire (SGRQ) and to test the predictive value of both tools against survival. Methods: Open cohort study of 120 COPD patients were followed up to 1 year. At the time of the inclusion, clinical data, forced spirometry, 6-minute walking distance, BODE index, and SGRQ were determined. Vital status and cause of death were documented at the end of follow-up. Results: The cohort’s mean score of age, SGRQ Total (SGRQ_Tot), and BODE index was 57.82 ± 7.58, 44.77 ± 13.81, and 3.04 ± 2.06, respectively. The correlation between SGRQ_Tot and BODE index was good (r = 0.611, P < 0.001). Regression analysis determined age, BODE, comorbidity index, and activity component of SGRQ (SGRQ_A) as predictors of mortality. The area under the curve for the BODE index was 0.801 vs. 0.692 for the SGRQ_A score indicating BODE score as best predictor of mortality. The best cut-off value for predicting mortality was 4.5 for BODE index and 62.5 for SGRQ_A score. Conclusion: Evaluation of HRQoL is an important entity for improving overall disease outcome of COPD.
{"title":"Prognostic assessment in COPD patients: BODE index and the health-related quality of life","authors":"K. Sharma, Avinash Jain, R. Takhar, Dps Sudan, V. Goyal, N. Goel, Vikram Singh","doi":"10.4103/jacp.jacp_31_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_31_19","url":null,"abstract":"Background: Chronic obstructive pulmonary disease (COPD) is a spreading epidemic of a debilitating disease impairing the health-related quality of life (HRQoL) of the patients. This study was conducted to identify the relationship between BODE (body mass index, obstruction, dyspnea, exercise capacity) index and the St George’s Respiratory Questionnaire (SGRQ) and to test the predictive value of both tools against survival. Methods: Open cohort study of 120 COPD patients were followed up to 1 year. At the time of the inclusion, clinical data, forced spirometry, 6-minute walking distance, BODE index, and SGRQ were determined. Vital status and cause of death were documented at the end of follow-up. Results: The cohort’s mean score of age, SGRQ Total (SGRQ_Tot), and BODE index was 57.82 ± 7.58, 44.77 ± 13.81, and 3.04 ± 2.06, respectively. The correlation between SGRQ_Tot and BODE index was good (r = 0.611, P < 0.001). Regression analysis determined age, BODE, comorbidity index, and activity component of SGRQ (SGRQ_A) as predictors of mortality. The area under the curve for the BODE index was 0.801 vs. 0.692 for the SGRQ_A score indicating BODE score as best predictor of mortality. The best cut-off value for predicting mortality was 4.5 for BODE index and 62.5 for SGRQ_A score. Conclusion: Evaluation of HRQoL is an important entity for improving overall disease outcome of COPD.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"6 - 13"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47037250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The Erasmus syndrome describes the association of generalised progressive scleroderma following exposure to silica with or without silicosis. We report a case of Erasmus Syndrome in a 55-year old labourer presenting with shortness of breath, arthralgia, Raynaud’s phenomenon, skin tightening and microstomia along with pulmonary arterial hypertension. Among investigations, serological markers were strongly positive, high-resolution computed tomography chest showed evidence of interstitial lung disease (ILD) with mediastinal lymphadenopathy and histopathology of skin biopsy were suggestive of systemic sclerosis. Correlating the occupational history, clinical features, haematological investigations and histological findings, a diagnosis of Erasmus syndrome was safely made.
{"title":"Erasmus Syndrome: Co-existence of silicosis and progressive systemic sclerosis in a 55 year old male","authors":"Jitendra Jalutharia, R. Dixit","doi":"10.4103/jacp.jacp_9_19","DOIUrl":"https://doi.org/10.4103/jacp.jacp_9_19","url":null,"abstract":"The Erasmus syndrome describes the association of generalised progressive scleroderma following exposure to silica with or without silicosis. We report a case of Erasmus Syndrome in a 55-year old labourer presenting with shortness of breath, arthralgia, Raynaud’s phenomenon, skin tightening and microstomia along with pulmonary arterial hypertension. Among investigations, serological markers were strongly positive, high-resolution computed tomography chest showed evidence of interstitial lung disease (ILD) with mediastinal lymphadenopathy and histopathology of skin biopsy were suggestive of systemic sclerosis. Correlating the occupational history, clinical features, haematological investigations and histological findings, a diagnosis of Erasmus syndrome was safely made.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"19 - 22"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48905557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pulmonary actinomycosis is a rare gram positive higher prokaryotic bacterial infection. We hereby present a case of 78-year old male presented with non-specific symptoms like cough, shortness of breath (SOB) and chest pain mimicking as pulmonary tuberculosis, fungal infection and lung cancer but was diagnosed to have pulmonary actinomycosis. From this, we want to emphasize that pulmonary actinomycosis should be evaluated in all patients that are not responding to anti-tubercular and lung cancer treatment.
{"title":"Pulmonary actinomycosis presenting as a pleural tumour","authors":"Neeraj Keyal, Raju Shrestha, Niru Nepal, Manish Nakarmi","doi":"10.4103/jacp.jacp_27_18","DOIUrl":"https://doi.org/10.4103/jacp.jacp_27_18","url":null,"abstract":"Pulmonary actinomycosis is a rare gram positive higher prokaryotic bacterial infection. We hereby present a case of 78-year old male presented with non-specific symptoms like cough, shortness of breath (SOB) and chest pain mimicking as pulmonary tuberculosis, fungal infection and lung cancer but was diagnosed to have pulmonary actinomycosis. From this, we want to emphasize that pulmonary actinomycosis should be evaluated in all patients that are not responding to anti-tubercular and lung cancer treatment.","PeriodicalId":30411,"journal":{"name":"The Journal of Association of Chest Physicians","volume":"8 1","pages":"23 - 25"},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42191996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：